Dr. Jaye is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
615 Michael St NE
Rm 105-B
Atlanta, GA 30322Phone+1 404-712-2805Fax+1 404-727-8538
Education & Training
- Emory University School of MedicineFellowship, Hematopathology, 1997 - 1998
- University of Alabama Medical CenterResidency, Pathology-Anatomic and Clinical, 1995 - 1997
- Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1991 - 1995
- Washington University in St. Louis School of MedicineClass of 1991
Certifications & Licensure
- GA State Medical License 1997 - 2025
- AL State Medical License 1995 - 1997
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematology
Publications & Presentations
PubMed
- 483 citationsA New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High AccuracyWilliam W.L. Choi, Dennis D. Weisenburger, Timothy C. Greiner, Miguel A. Piris, Alison H. Banham
Clinical Cancer Research. 2009-09-01 - 219 citationsFunctional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target.Dharminder Chauhan, Ajita V. Singh, Mohan Brahmandam, Ruben D. Carrasco, Madhavi Bandi
Cancer Cell. 2009-10-06 - 25 citationsBortezomib-induced heat shock response protects multiple myeloma cells and is activated by heat shock factor 1 serine 326 phosphorylation.Shardule P. Shah, Ajay K. Nooka, David L. Jaye, Nizar J. Bahlis, Sagar Lonial
Oncotarget. 2016-07-26
Abstracts/Posters
- Utility and Patterns of Use of PET/CT and Bone Marrow Biopsy for Staging in Non-Hodgkin Lymphoma in the Clinical Setting: A Retrospective Analysis Using the LEO DatabaseDavid L. Jaye, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular LymphomaDavid L. Jaye, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Vulnerable Elders Survey-13 (VES-13) Predicts 1-Year Mortality Risk in Newly Diagnosed Non-Hodgkin Lymphoma (NHL)David L. Jaye, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Outcomes of Myeloma Patients with Deletion 1p Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVD) Therapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United States2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- 'Treason' by Immune System Cells Aids Growth of Multiple MyelomaOctober 8th, 2009
Grant Support
- GI Inflammation: Novel G-Protein Coupled PMN ResponsesNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: